Jilin Wutai Pharmaceutical Group Co., Ltd. is a well-known pharmaceutical enterprise group in China. Since the 1980s, it has entered the business world, pioneering and enterprising, and operates honestly, and has gradually developed into a combination of pharmaceutical production, scientific research and development, wholesale and retail, real estate development, healthy food production and development. A powerful enterprise group that integrates diversified operations across industries.

Boy Excellence:

The group owns many wholly-owned subsidiaries including Jilin Wutaigankang Pharmaceutical Co., Ltd., Jilin Wutaigankang Pharmaceutical Co., Ltd., and Jilin Northern Pharmaceutical Co., Ltd. The company's sales network covers more than 100 large and medium-sized cities across the country. So far, Gankang® product sales cover nearly 520,000 retail pharmacies, community service stations, etc., and the product sales have hit new highs in a row.

The company now has more than 2,000 employees, including more than 50 senior management personnel and more than 80 senior scientific researchers. It has played its talents under the employment mechanism of the company's "goodness is like water, follow the trend, people-oriented, and burst out potential" to develop with the company.

The group has adhered to the corporate spirit of "loyalty, tenacity, diligence and persistence" for many years, focused on the production and research and development of drugs, upholding a rigorous craftsmanship style, and is committed to becoming a leading enterprise in the field of medicine and health in my country.

Keep improving and moving forward:

The group currently has two pharmaceutical production bases, and its strong production capacity has laid a solid foundation for the development of the group and the production of medicines.

"Gankang" production base - Jilin Wutai Gankang Pharmaceutical Co., Ltd. is located in Changchun Economic and Technological Development Zone. It was established in September 1999 with a total investment of RMB 120 million and covers an area of ​​more than 60,000 square meters. The construction area is about 16,000 square meters, and it has many internationally advanced production lines, with an annual production capacity (single shift) of 1 billion tablets and 300 million capsules. In 2002, it was the first to pass the national GMP pharmaceutical manufacturer certification at one time. Since 2008, it has been recognized as a "high-tech enterprise" for many consecutive times.

"Wu Tai" pharyngitis tablet production base - Jilin Wu Tai Gankang Pharmaceutical Co., Ltd. is located on the beautiful Songhua River. It completed the relocation of the old site and the construction of the factory in the end of 2003. The total investment is RMB 80 million and covers an area of ​​RMB 100 million. More than 50,000 square meters, and passed the national GMP certification in 2004 and the new version of GMP certification in 2014. It now has 12 production lines including tablets, capsules, ointments, oral liquids, granules, and Chinese patent medicines, with more than 50 varieties. It is a pharmaceutical production base with international advanced production levels.

In 2020, Wutai Pharmaceutical Industrial Park located in Xinglongshan Free Trade Zone in Changchun was officially opened. Phase I of the Industrial Park covers an area of ​​about 100,000 square meters, with a total construction area of ​​750,000 square meters. 100 million yuan is invested to introduce advanced equipment and realize dedicated line production; it now has a modern comprehensive preparation workshop, a dedicated energy power center, and a smart logistics warehouse Six functional centers, including the center, sewage treatment station, comprehensive quality inspection office building, and leisure service center, are committed to building a first-class domestic pharmaceutical industry complex.

The second phase of Wutai Pharmaceutical Industrial Park, with a planned building area of ​​150,000 square meters, mainly focusing on traditional Chinese medicine production, including preparation building, R&D center, traditional Chinese medicine extraction workshop, pilot workshop, office building and related supporting facilities. It has the most production capacity in Jilin Province. Large traditional Chinese medicine production workshop. After reaching full capacity, the annual total output value is expected to be 3 billion yuan, and the annual profit and tax can reach 500 million yuan. After all the first and second phases of the project are put into production, the annual total output value can reach 5 billion yuan and the total profit and tax will reach 1 billion yuan, which will become a modern pharmaceutical production base with international standards.